Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Antidepressants in Parkinson's Disease

ClinicalTrials.gov ID: NCT00086190

Public ClinicalTrials.gov record NCT00086190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00086190
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Rochester
Other
Enrollment
115 participants

Conditions and interventions

Interventions

  • paroxetine Drug
  • placebo Other
  • venlafaxine Drug

Drug · Other

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
Oct 31, 2009
Completion
Oct 31, 2009
Last update posted
Jan 3, 2013

2005 – 2009

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
14
Facility City State ZIP Site status
University of California San Francisco San Francisco California 94143
University of Florida Gainesville Florida 32610
University of Miami Miami Florida 33136
Emory University School of Medicine Atlanta Georgia 30322
University of Kentucky Lexington Kentucky 40536
Johns Hopkins University Baltimore Maryland 21218
University of Maryland Baltimore Maryland 21250
Beth Israel Deaconess Medical Center, Dept. of Neurology E/KS 430, 330 Brookline Avenue Boston Massachusetts 02215
Washington University School of Medicine St Louis Missouri 63110
University of Rochester Rochester New York 14627
Medical University of Ohio Toledo Ohio
Oregon Health Sciences University Portland Oregon 97239
University of Tennessee-Memphis Memphis Tennessee 38163
Baylor College of Medicine, 6550 Fannin, Suite 1801 Houston Texas 77030
University of Virginia Charlottesville Virginia 22901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00086190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2013 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00086190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →